)
)
)
Cytocast
Cytocast is a TechBio company using AI and digital-twin–based tissue simulations to predict the side effects of chemical compounds and drug candidates earlier in their development. The Cytocast Digital Twin Platform™ combines deep learning–based target prediction, digital replicas of 29 human tissue types, and mechanistic simulation of compound interactions to deliver rapid, interpretable safety insights that help R&D teams focus resources on the most promising candidates. Founded in 2021 by scientists from Pázmány Péter Catholic University, Budapest, Hungary, Cytocast is backed by European venture and angel investors and collaborates with leading pharma and biotech partners.
Address
BudapestHungary
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)